Key result
Diabetic nephropathy in patients with type 2 diabetes was associated with significantly worse echocardiographic parameters, including lower TAPSE and heavier left ventricular mass (P ≤ 0.05).
Why the study?
Cardiovascular changes are a major cause of mortality in diabetic patients with diabetic nephropathy, prompting evaluation of structural and functional echocardiographic changes in patients with versus without diabetic nephropathy.
Do T2DM patients with diabetic nephropathy have worse echocardiographic structural and functional cardiovascular changes compared to those without diabetic nephropathy?
Cross-Sectional (n=60)
Do T2DM patients with diabetic nephropathy have worse echocardiographic structural and functional cardiovascular changes compared to those without diabetic nephropathy?
p-value: p=≤ 0.05
Type 2 diabetes patients with diabetic nephropathy exhibit more pronounced adverse structural and functional echocardiographic changes compared to those without nephropathy, indicating higher cardiovascular risk.
May warrant closer cardiac monitoring in T2DM with nephropathy; hypothesis-generating and requires prospective confirmation.
Background: Diabetes mellitus (DM) is a metabolic disorder of multiple etiologies. Cardiovascular changes are one of the important macro vascular complications which are a major cause of mortality in diabetic patients with diabetic nephropathy. The aim of this work was to evaluate the structural and functional cardiovascular changes using echocardiography in diabetic patients with diabetic nephropathy (DN) in comparison with those without diabetic nephropathy. Methods: This observational cross-sectional study was carried out on 60 diabetic patients with type 2 diabetes mellitus (T2DM) only or had T2DM with DN Patients were subdivided in to two equal groups: group A included patients without DN and group B included patients with DN. All patients were subjected to laboratory investigations, echocardiography (tricuspid annular plane systolic excursion (TAPSE), pulmonary artery pressure measuring, left ventricular systolic and diastolic function assessment). Results: There was a significantly lower Hb and significantly higher creatinine level and AL/CR ratio in group B in comparison to group A. There was significantly higher number of sclerotic aortic valve patients, higher numbers of low TAPSE, higher estimated systolic pulmonary artery pressure (ESPAP), higher end diastolic diameter (EDD), higher end systolic diameter (ESD), heavier left ventricular mass and thicker posterior wall thickness in group B in comparison to group A (P ≤ 0.05). There was a positive relationship between AL/CR ratio and EDD, left ventricular mass, TAPSE, and posterior wall thickness, while negative relationship between it and ESD in the two studied groups, and it was found that high EPASP and sclerosis of the Aortic valve were more prevalent with DN group. Conclusions: Risks of cardiovascular events increase substantially with increasing stage of kidney disease in T2DM patients. Asymptomatic diabetic subjects are at high risk for major adverse cardiovascular events, such as those with, chronic diabetic kidney disease (DKD), or proteinuria.
No takes yet. Share an insight, caveat, or question.
Barakat et al. (2022) conducted a cross-sectional in Type 2 diabetes mellitus with or without diabetic nephropathy (n=60). Diabetic nephropathy vs. Without diabetic nephropathy was evaluated on Structural and functional cardiovascular changes using echocardiography (p=≤ 0.05). Diabetic nephropathy in patients with type 2 diabetes was associated with significantly worse echocardiographic parameters, including lower TAPSE and heavier left ventricular mass (P ≤ 0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: